Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-08-08
1976-09-21
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
250303, 260429R, 260534S, A61K 4300, A61K 2900, G01T 1161, G21H 502
Patent
active
039819809
ABSTRACT:
A diagnostic substance for cholescintigraphy which is formed by the reaction of pyridoxal and amino acids labelled with a radionuclide, in pyrogen-free water, the reaction product being adjusted to a pH of 8 to 9 and then autoclaved and cooled to produce a sterile, pyrogen-free non-antigenic solution for injection for biliary scanning.
REFERENCES:
mcFarlane, "Biological Studies with Labelled Amino Acids and Proteins", Isotopes in Biochemistry and Physiology, Part 2, United Nations Publication, 1958.
Baker Richmond J.
Bellen Johan C.
Nucker Christine M.
Padgett Benjamin R.
The Council of the Institute of Medical and Veterinary Science
The University of Adelaide (Anti-Cancer Foundation)
LandOfFree
Radiopharmaceuticals for cholescintigraphy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiopharmaceuticals for cholescintigraphy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopharmaceuticals for cholescintigraphy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1413940